In contemporary medicine, high-cost specialty medications, including biologics and innovative therapies, have transformed the treatment of complicated diseases such as rheumatoid arthritis, cancer, and multiple sclerosis. Although the medications have the promise to change lives, they pose a heavy administrative burden: an exhaustive prior authorization process.
For medical practices, obtaining approval for these medications is among the most daunting elements of the entire revenue cycle. The stakes are extremely high; a denial not only postpones life-saving treatment for an in-need patient but can also lead to a substantial financial setback for the practice if a “buy and bill” model is employed.
The crossroads of clinical need and fiscal gate keeping necessitate this being a priority area that each practice must excel in. Delayed or partial submissions create a painful cycle of denials, appeals, and administrative costs that become stressful for personnel and the medical billing office. So much so that just prior authorization work takes up almost two full days of the week.
But by taking a proactive, diligent, and strategic method, practices can expedite the prior authorization process so that patients receive the treatments they require in a timely fashion.
1. Become Experts at the Payer’s Playbook: Formulary and Step Therapy
Even before you start completing a form, the most important thing is to familiarize yourself with the particular rules of the patient’s insurance plan. Every payer has their own playbook for expensive drugs.
- Verify Formulary Status: The initial question always is, Is this particular drug on the payer’s formulary? If not, the request will be an automatic denial. Verify the formulary status first to save time. If the prescribed medication is non-preferred, the documentation will have to be even stronger to explain why formulary options are not clinically appropriate.
- Bend Step Therapy Requirements: Patients must attempt and fail on one or more of the lower-cost, preferred medications before payers will approve a more costly specialty drug under this “step therapy” or “fail-first” policy. This is a significant barrier. Your prior authorization request has to include clear, chronological documentation of what exact drugs were attempted, for how long, and why they were stopped (e.g., because of lack of efficacy or intolerable side effects). Without this documented history, the submission is incomplete.
2. Build an Ironclad Clinical Case in Your Documentation
The decision-maker at the insurance company is a clinician who was not in the exam room with you. Your documentation must be so clear and compelling that it leaves them with no doubt as to the medical necessity of the prescribed drug. Your submission packet should tell a powerful clinical story:
- A Comprehensive Patient History: Clearly define the patient’s diagnosis, the severity of the illness, and its effects on their quality of life and functional capacity.
- Objective Clinical Evidence: Add definite, objective information to substantiate the diagnosis and severity. This is done by affixing lab findings, imaging studies, and results from standardized measures. This information is much more convincing than opinion-laden descriptions alone.
- The “Why Now?”: Clearly indicate why this costly medication is required at this particular juncture. What has altered in the patient’s state? Why are step-therapy medications no longer viable?
This detailed clinical picture anticipates the payer’s inevitable questions and shows a rigorous, evidence-driven treatment strategy.
3. Send a Flawless, Mistake-Free Packet
After building the clinical case, the submission itself must be flawless from an administrative standpoint. Simple clerical errors are one of the most common and most avoidable reasons for initial rejections, which kick off a new cycle of delays. Before clicking “submit”, double-check every detail:
- Patient Demographics: Verify the patient’s name, date of birth, and policy number are an exact match to what the insurer has on file.
- Provider Information: Validate the prescribing provider’s name and NPI number.
- Drug and Dosing Information: The name of the drug, dosage, and frequency need to be written as prescribed.
- Correct Forms: Utilize the payer’s most recent, specific prior authorization form for the medication. Utilizing an old form will result in automatic rejection.
This careful attention to detail is an essential part of the medical billing process, for that which is submitted cleanly is the quickest route to approval and, ultimately, a paid claim.
4. Active Follow-Up and Effective Appeals
Requesting is not submitting. An inactive “wait and see” mentality is a recipe for unwarranted delays.
- Confirm Receipt and Track Status: Once submitted, verify that the request has reached the payer. If it is being submitted through an electronic portal, monitor the status on a daily basis. This aggressive follow-up ensures that the request is not lost in a queue.
- Prepare for Peer-to-Peer Reviews: In the event of a denial, the second move is oftentimes a peer-to-peer review, where the physician prescriber directly engages with a medical director from the insurance carrier. Have the patient’s record handy, with all the important clinical data and talking points summarily noted. A well-prepared P2P discussion is frequently the quickest way to reverse a denial.
- Engage the Patient: Active patients can be strong advocates. Inform them of the progress, and if there’s a lag, they can also contact their insurer to ask why it has been held up, providing another degree of pressure.
By treating the prior authorization for costly medications as a multifaceted process instead of an administrative one, practices can significantly enhance their success rate. This could further be boosted by delegating prior authorization work to a group of specialist medical billing professionals. This strategic approach not only speeds up access to life-saving treatments for patients but also fortifies the practice’s overall revenue cycle.
